1. Home
  2. CAL vs ORKA Comparison

CAL vs ORKA Comparison

Compare CAL & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.33

Market Cap

432.0M

ML Signal

HOLD

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$82.90

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAL
ORKA
Founded
1878
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.0M
5.6B
IPO Year
1994
1997

Fundamental Metrics

Financial Performance
Metric
CAL
ORKA
Price
$12.33
$82.90
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$15.00
★ $92.50
AVG Volume (30 Days)
547.9K
★ 808.4K
Earning Date
05-28-2026
05-13-2026
Dividend Yield
★ 2.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.14
N/A
Revenue
★ $85,513,000.00
N/A
Revenue This Year
$5.19
N/A
Revenue Next Year
$2.45
N/A
P/E Ratio
$5.86
★ N/A
Revenue Growth
★ 0.46
N/A
52 Week Low
$8.80
$18.19
52 Week High
$15.04
$115.52

Technical Indicators

Market Signals
Indicator
CAL
ORKA
Relative Strength Index (RSI) 48.02 33.54
Support Level $11.54 $29.45
Resistance Level $14.15 $97.45
Average True Range (ATR) 0.53 4.60
MACD 0.06 -1.12
Stochastic Oscillator 57.94 7.73

Price Performance

Historical Comparison
CAL
ORKA

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Share on Social Networks: